Philips – BiPAP & DreamStation CPAP Class I Recall & Potential Damages – 18 October 2021

  • Public Equity
  • Healthcare
  • North America


Executive at KJC Law Group


  • Philips Respironics’ (AMS: PHIA) (NYSE: PHG) voluntary recall of certain ventilators, BiPAP (bi-level positive airway pressure) and CPAP (continuous positive airway pressure) sleep apnoea devices following FDA issuing a safety communication
  • Trial process deep dive – pre-trial proceedings, likely timeline and potential sticking points, using Bayer-Monsanto (ETR: BAYN) Roundup as a case study
  • Criteria for case filings, predicting potential case numbers and payouts to each plaintiff
  • MDL (multi-district lawsuit) vs class action nuances and breakdown of medical vs non-medical filings


Gain access to Premium Content

Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.

    One week, unlimited access to over 25,000 transcripts
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited